Utilization of NGS in Genetic Diagnostics of Inherited Retinal Diseases

Description of Program Content:

Our current understanding of the genetic basis of IRD and the present and emerging reasons for offering genetic diagnostics for these patients will be discussed. A focus will be placed on the challenges involved with next generation sequencing (NGS) and considerations that should be made when selecting optimal testing for patients. The webinar will describe innovations Blueprint Genetics has implemented to address these challenges, as well as, an outline of our experiences with thousands of IRD patients analyzed at Blueprint to date.

 

If you missed this webinar, you can find the video here.

Last modified: 01.11.2018